Kamada (KMDA) Current Deferred Revenue (2012 - 2026)
Kamada's (KMDA) quarterly Current Deferred Revenue came in at $67000.0 in Q1 2026, down 67.32% YoY from $205000.0 in Q1 2025, and down 93.44% on a QoQ basis from $1.0 million in Q3 2025.
Kamada (KMDA) Current Deferred Revenue (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Current Deferred Revenue data on file, last reported at $67000.0 in Q1 2026.
- Quarterly Current Deferred Revenue fell 67.32% year-over-year to $67000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67000.0 (down 67.32% YoY) and the FY2024 annual result came in at $171000.0, up 15.54% from the prior year.
- Current Deferred Revenue declined to $67000.0 in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.0 million in Q3 2025 to a low of $40.0 in Q3 2022.
- A 5-year average of $128278.7 and a median of $40000.0 in 2022 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue plunged 100.0% — and 2023, when it soared 37400.0%.
- Tracing KMDA's Current Deferred Revenue over 5 years: stood at $35000.0 in 2022, then jumped by 322.86% to $148000.0 in 2023, then climbed by 15.54% to $171000.0 in 2024, then surged by 497.66% to $1.0 million in 2025, then plunged by 93.44% to $67000.0 in 2026.
- The last three Current Deferred Revenue figures came in at $67000.0 (Q1 2026), $1.0 million (Q3 2025), and $177000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Kamada | 462.32 Mn | 432.85 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 161,000.00 |
| Mar 31, 2026 | 67,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 177,000.00 |
| Mar 31, 2025 | 205,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 148,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 419.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 40.00 |
| Jun 30, 2022 | 40,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 3.58 Mn |
| Jun 30, 2021 | 3.03 Mn |